Congenital CMV is the most common nongenetic cause of hearing loss in children and a leading cause of other neurologic ...

A national study involving a UT Southwestern Medical Center neonatologist and pediatric infectious diseases specialist suggests that a screening test routinely performed in newborns is not very good ...

When we found out we were expecting our third child, we were overjoyed. No pregnancy is easy, of course, and we already had our hands full with two little ones. But this was our third time around, and ...

Laura Gibson is an associate professor of medicine and of pediatrics at UMass Chan Medical School. CMV belongs to the same virus family as cold sores and chickenpox and, like those viruses, lives in ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved the first in vitro diagnostic test used to monitor cytomegalovirus treatment in hematopoietic ...

First FDA-approved laboratory test for quantifying DNA of potentially deadly virus helps physicians manage organ transplant patients on antiviral therapy "With this new test, diagnostic laboratories ...

Minnesota is the first U.S. state to universally test newborns for cytomegalovirus, an easily transmissible virus and a leading cause of infant hearing loss and congenital birth defects. The ...

- CMV is the most common and serious viral infection in transplant patients - The cobas® CMV test provides reliable, reproducible, high-quality results for clinical decision-making - CMV viral load ...

Assay will help monitor the effects of antiviral therapy in organ transplant patients. Roche’s Cobas® AmpliPrep/Cobas TaqMan® CMV test for evaluating cytomegalovirus (CMV) load received FDA premarket ...

PLEASANTON, Calif., June 5, 2017 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received FDA approval for the cobas® CMV (cytomegalovirus) test for use on the fully ...